A retrospective study to determine real-world long-term outcomes of guselkumab treatment in patients with psoriasis in a real-world setting
Latest Information Update: 07 Feb 2023
At a glance
- Drugs Guselkumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Therapeutic Use
- Acronyms BIOREP
Most Recent Events
- 07 Feb 2023 New trial record
- 01 Feb 2023 Results published in the Dermatology and Therapy